Cervical cancer: Screening, diagnosis and staging

Journal of B.U.ON.

Volumn 21, Issue 2, 2016, Pages 320-325

  Tsikouras, Panagiotis ^a   Zervoudis, Stefanos ^b,c   Manav, Bachar ^a   Tomara, Eirini ^c   Iatrakis, George ^b,c   Romanidis, Constantinos ^a   Bothou, Anastasia ^c   Galazios, George ^a  

^a University General Hospital   (Greece)

^b UNIVERSITY OF WEST ATTICA   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cervical cancer; Diagnosis; FIGO 2009 staging; HPV screening

Indexed keywords

ADENOCARCINOMA IN SITU; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; DNA VIRUS; FOLLOW UP; HUMAN; INCIDENCE; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PELVIC EXAMINATION; PRACTICE GUIDELINE; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; AGE; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY CANCER DIAGNOSIS; FEMALE; GENETICS; HUMAN PAPILLOMAVIRUS DNA TEST; MIDDLE AGED; PAPILLOMAVIRIDAE; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

AGE FACTORS; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84976472753     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Moshkovich O, Lebrun-Harris L, Makaroff L et al. Challenges and opportunities to im-prove cervical cancer screening rates in US Heath centers through patient-centered med-ical home transformation. Adv Prev Med 2015;2015:182073.
2. Benard VB, Thomas CC, King J, Massetti GM, Doria-Rose VP, Saraiya M. Vital signs: cervical cancer incidence, mortality, and screening - United States, 2007- 2012. MMWR Morb Mortal Wkly Rep 2014;63:1004-1009.
3. Soutter WP, de Barros Lopes A, Fletcher A et al. Invasive cervical cancer after con-servative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-980.
4. Gustafsson L, Pontén J, Bergström R, Adami HO. International incidence rates of inva-sive cervical cancer before cytological screening. Int J Cancer 1997;71:159-165.
5. Denny L. Cytological screening for cervical cancer prevention. Best Pract Res Clin Ob-stet Gynaecol 2012;26:189-196.
6. Vaisy A, Lotfinejad S, Zhian F. Risk of cancer with combined oral contraceptives use among Iranian women. Asian Pac J Cancer Prev 2014;15:5517-5522.
7. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diag-nosis and treatment of cervical carcinomas. Number 35, May 2002. Int J Gynaecol Ob-stet 2002;78:79-91.
8. Gorenoi V, Schönermark MP, Hagen A. Benefits and risks of hormonal contraception for women. GMS Health Technol Assess 2007;10;3.
9. Mayer DK, Carlson J. Smoking patterns in cancer survivors. Nicotine Tob Res 2011;13:34-40.
10. Lie AK, Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 2008;8:405-415.
11. Iftner T, Villa LL. Chapter 12: Human pappillomavirus technologies. J Natl Cancer Inst Monogr 2003;31:80-88.
12. Halec G, Alemany L, Lloveras B et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol 2014;234:441-451.
13. Agorastos T, Chatzistamatiou K, Katsamagkas T et al. Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in comparison to Cytology. PLoS One 2015;10:e0119755.
14. Koss LG. Chapter Part I: Inflammatory processes; Part II: Other benign disorders of the cervix and vagina. In: Winters R, Orem E, Gibbons T (Eds): Diagnostic Cytology (4th Edn). JB Lippincott Co, Philadelphia, 1992, pp 314-370.
15. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Socie-ty for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516-542.
16. McKee SJ, Bergot AS, Leggatt GR. Recent progress in vaccination against human papillomavirus-mediated cervical cancer. Rev Med Virol 2015;1:54-71.
17. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Socie-ty for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Can-cer J Clin 2012;62:147-172.
18. Saslow D, Solomon D, Lawson HW et al. American Cancer Society, American Socie-ty for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012;16:175-204.
19. Saatli B, Olgan S, Gorken IB et al. Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study. Arch Gynecol Obstet 2014;289:1331-1335.
20. Nyirjesy I. Conization of Cervix. Medscape. Updated: Jan 22, 2015
21. Fontaine PL, Saslow D, King VJ. ACS/ASCCP/ ASCP guidelines for the early detec-tion of cervical cancer. Am Fam Physician 2012;86:501,506-507.
22. Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health 2014;6:555-564.
23. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometri-um. Int J Gynaecol Obstet 2009;105:103-104.
24. Sobin L, Wittekind CH. UICC International Union Against Cancer (6th Edn), Geneva, Switzerland, 2002, pp 155-157.
25. Seski JC, Abell MR, Morley GW. Microinvasive squamous carcinoma of the cervix: definition, histologic analysis, late results of treatment. Obstet Gynecol 1977;50: 410-414.
26. Ostör AG. Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993;12:193-207.
27. Coleman DV, Evans DMD. Microinvasive and occult invasive squamous carcinoma. In: Neville AM, Walker F, Gottlied LS (Eds): Biopsy pathology and cytology of the cervix. Chapman and Hall Medical University Press, Cambridge, 1988, pp 240-259.
28. Sevin BU, Nadji M, Averette HE, Hilsenbeck S, Smith D, Lampe B. Microinvasive carcinoma of the cervix. Cancer 1992;70:2121-2128.
29. Copeland LJ, Silva EG, Gershenson DM, Morris M, Young DC, Wharton JT. Super-ficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:307-312.
30. Shepherd JH, Milliken DA. Conservative surgery for carcinoma of the cervix. Clin Oncol (R Coll Radiol) 2008;20:395-400.
31. Cibula D, Slama J, Fischerova D. Update on abdominal radical trachelectomy. Gyne-col Oncol 2008;111:S111-115.
32. Wethington SL, Cibula D, Duska LR et al. An international series on abdominal radi-cal trachelectomy: 101 patients and 28 pregnancies. Int J Gynecol Cancer 2012;22:1251-1257.
33. Ungár L, Smith JR, Pálfalvi L, Del Priore G. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet Gynecol 2006;108:811-814.
34. Capîlna ME, Ioanid N, Scripcariu V, Gavrilescu MM, Szabo B. Abdominal radical trachelectomy: a Romanian series. Int J Gynecol Cancer 2014;24:615-619.
35. Nishio H, Fujii T, Sugiyama J et al. Reproductive and obstetric outcomes after radical abdominal trachelectomy for early-stage cervical cancer in a series of 31 pregnancies. Hum Reprod 2013;28:1793-1798.
36. Vargo JA, Beriwal S. Image-based brachytherapy for cervical cancer. World J Clin Oncol 2014;5:921-930.
37. Halaska M, Robova H, Pluta M, Rob L. The role of trachelectomy in cervical cancer. Ecancermedicalscience 2015;9:506.